Collaboration between Teva and Launch Therapeutics for Advancing Asthma Rescue Inhaler Program
Monday, 1 April 2024, 13:05
Collaboration for Asthma Innovation
Teva Pharmaceutical and Launch Therapeutics have partnered to advance the clinical development of a dual-action asthma rescue inhaler program.
Strategic Alliance for Patient Care
This collaboration aims to provide innovative solutions to meet the urgent needs of asthma patients, enhancing their treatment options.
- Accelerated Clinical Research: The joint efforts seek to expedite the research process, bringing new therapies to patients faster.
- Industry Support: Abingworth's funding injects resources into the program, underlining industry commitment to asthma treatment innovation.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.